Clinical Trial Update: A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase II study evaluating the efficacy and safety of clofarabine in patients with aggressive non-Hodgkin lymphoma. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Clofarabine (clofarabine)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED